About This EventOKYO Pharma Ltd (Nasdaq: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback